Tinzaparin Sodium — Drug Intelligence | 10 EU Trials

Filter these 10 trials by condition, phase, country and more.

Open in Search →

10 Registered trials

7 Recruiting

1 Completed trials

10 Sponsors

9 Countries

Phase III

Phase II

Phase IV

Phase III: 5 Phase II: 1 Phase IV: 4

Indications tested

Colorectal cancer metastatic 1 Thrombosis 1 Pulmonary embolism 1 Joint stabilisation 1 Intensive care 1 Tumour thrombosis 1

Sponsors using this IMP

Rigshospitalet 2 Centre Hospitalier Universitaire D'Angers 1 Centre Hospitalier Universitaire De Saint Etienne 1 Grupo Gallego De Investigacion En Tumores Digestivos 1 HUS-Yhtymae 1 Institut Gustave Roussy 1 Institute Of Molecular Medicine And Biomedical Research 1 Region Hovedstaden 1 Region Oestergoetland 1 University Of Helsinki 1

All trials

10 total

The impact of Thromboprophylaxis on Progression Free Survival of Patients with Advanced Pancreatic Cancer. The Pancreatic Cancer & Tinzapari… Pending

2024-520043-17-00 Phase III 1 country Institute Of Molecular Medicine And Biomedical Research
Pulmonary Embolism & Anticoagulation Evaluation in Cancer Patient - PEACE Pending

2025-524110-28-00 Phase IV 1 country Region Hovedstaden
The Intensive Care Platform Trial (INCEPT) Recruiting

2024-516208-41-00 Phase IV 5 countries Rigshospitalet
STRATIFY II Recruiting

2024-515712-45-00 Phase IV 1 country Rigshospitalet
Prevention of thromboembolism during pancreatic cancer treatments - link to prognosis and relapse of the disease. Recruiting

2024-512475-12-01 Phase IV 1 country HUS-Yhtymae; University Of Helsinki
RIVACAST - RIVAroxaban versus low-molecular weight heparin in patients with lower limb trauma requiring brace or CASTing Recruiting

2023-509905-62-00 Phase III 1 country Centre Hospitalier Universitaire D'Angers
Study evaluating thromboprophylaxis in patients with advanced germ cell tumours of good or intermediate prognosis Recruiting

2022-502426-41-00 Phase III 1 country Institut Gustave Roussy
Best Antithrombotic Therapy in patients with acute Venous ThromboEmbolism while taking antiplatelets: the BAT-VTE Recruiting

2022-500974-33-00 Phase III 1 country Centre Hospitalier Universitaire De Saint Etienne
The Effect of tinzaparin on Biomarkers in FIGO Stage III-IV Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy – A randomized pilot… Recruiting

2024-515450-24-00 Phase II 1 country Region Oestergoetland
Prophylaxis of venous thromboembolic disease with LMWH (TINzaparin) in patients with metastatic colorectal cancer who start the first line o… Ended

2023-508860-31-00 Phase III 2 countries Grupo Gallego De Investigacion En Tumores Digestivos

Showing 1–10 of 10 trials

← All drugs A–Z